Skip to main content

Peer Review reports

From: Earth-friendly-assessed silver-nanoparticles spectrophotometric method for rapid and sensitive analysis of Molnupiravir, an FDA-approved candidate for COVID-19: application on pharmaceutical formulation and dissolution test

Original Submission
22 Apr 2022 Submitted Original manuscript
14 Jul 2022 Reviewed Reviewer Report
1 Nov 2022 Reviewed Reviewer Report - Abrar Ahmad
13 Nov 2022 Author responded Author comments - Ahmed R. Mohamed
Resubmission - Version 2
13 Nov 2022 Submitted Manuscript version 2
13 Dec 2022 Reviewed Reviewer Report
2 Jan 2023 Author responded Author comments - Ahmed R. Mohamed
Resubmission - Version 3
2 Jan 2023 Submitted Manuscript version 3
3 Jan 2023 Author responded Author comments - Ahmed R. Mohamed
Resubmission - Version 4
3 Jan 2023 Submitted Manuscript version 4
22 Feb 2023 Author responded Author comments - Ahmed R. Mohamed
Resubmission - Version 5
22 Feb 2023 Submitted Manuscript version 5
Publishing
28 Feb 2023 Editorially accepted
10 Mar 2023 Article published 10.1186/s13065-023-00933-2

You can find further information about peer review here.

Back to article page